sglt2 inhibitors and glp-1 receptor agonists together in Type 2 Diabetes: Pleiotropic Cardiometabolic Effects and Add-on Value of a Combined Therapy | Drugs GLP1 Receptor Agonists vs SGLT2-I
Description
DOI: 10.1016/j.jacc.2021.10.041
[3] demonstrated that GLP-1RAs might be the preferred treatment for T2DM while simultaneously reducing the risk of lung cancer
While their name may cause people to assume they are patches containing semaglutide, tirzepatide or another GLP-1 drug, it is worth noting that the currently available GLP-1 patches contain herbal supplements, not GLP-1 agonist drugs
however, it requires self-administration via syringe , increasing complexity and risk of dosing errors
N Engl J Med 381:24972505
10.1016/j.lfs.2020.118966 [DOI] [PubMed] [Google Scholar] 195.Petit JM, Vergs B
